IEX •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization600.55 mln
Float113 mln
Earnings Date08/12/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.33
Highly reliable
Relative Strength
22
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-54.20
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Aclaris Therapeutics is a US-based clinical-stage company focused on developing new treatments for immune and inflammatory diseases. Its pipeline includes several drug candidates targeting conditions such as atopic dermatitis, asthma, chronic obstructive pulmonary disease, and other immune-driven disorders. Founded in 2012 and based in Wayne, Pennsylvania, the company is advancing multiple compounds through early- and mid-stage clinical trials.
